Department of Urology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Department of Urology, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Scand J Urol. 2020 Jun;54(3):235-240. doi: 10.1080/21681805.2020.1766561. Epub 2020 May 21.
In 2005, the National Swedish Kidney Cancer Register (NSKCR) was set up to collect data on newly diagnosed patients with renal cell carcinoma (RCC). In 2015, the NSKCR was linked to a number of national healthcare and demographic registers to construct the Renal Cell Cancer Database Sweden (RCCBaSe). The aim was to facilitate research on trends in incidence, effects of treatment and survival, with detailed data on tumour characteristics, treatment, pharmaceutical prescriptions, socioeconomic factors and comorbidity. All patients registered in the NSKCR between 2005 and 2014 were included. For each case, ten controls and first-degree relatives for cases and controls were identified. The RCCBaSe was created linking all cases, controls and first-degree relatives to a number of national registers with information on co-morbidity, socioeconomic factors and pharmaceutical prescriptions. Between 2005 and 2014, a total of 9,416 patients with RCC were reported to the NSKCR. 94,159 controls and a total cohort of 575,007 individuals including cases, controls and first-degree relatives were identified. Linkage to the Swedish cancer register resulted in 106,772 matches. When linked to the National patient register, 432,677 out-patient and 471,359 in-patient matches were generated. When linked to the Swedish renal registry 1,778 matches were generated. Linkage to the Prescribed drug register resulted in 448,084 matches and linkage to the The Longitudinal integration database for health insurance and labour market studies database resulted in 450,017 matches. By linking the NSKCR to several Swedish national databases, a unique database for RCC research has been created.
2005 年,成立了瑞典国家肾细胞癌登记处(NSKCR),以收集新诊断的肾细胞癌(RCC)患者的数据。2015 年,NSKCR 与多个国家卫生保健和人口登记处联系,建立了瑞典肾细胞癌数据库(RCCBaSe)。其目的是促进对发病率、治疗效果和生存率趋势的研究,提供肿瘤特征、治疗、药物处方、社会经济因素和合并症的详细数据。所有 2005 年至 2014 年在 NSKCR 登记的患者均被纳入研究。为每个病例,确定了 10 名对照和病例及对照的一级亲属。通过将所有病例、对照和一级亲属与一些国家登记处联系起来,创建了 RCCBaSe,这些登记处包含了合并症、社会经济因素和药物处方信息。在 2005 年至 2014 年期间,共有 9416 例 RCC 患者向 NSKCR 报告。确定了 94159 名对照和总共 575007 名个体(包括病例、对照和一级亲属)的队列。与瑞典癌症登记处的链接产生了 106772 次匹配。与国家患者登记处链接时,生成了 432677 次门诊和 471359 次住院匹配。与瑞典肾脏登记处的链接产生了 1778 次匹配。与处方药物登记处的链接产生了 448084 次匹配,与纵向一体化医疗保险和劳动力市场研究数据库的链接产生了 450017 次匹配。通过将 NSKCR 与几个瑞典国家数据库联系起来,创建了一个用于 RCC 研究的独特数据库。